Ryanair (LON:0RYA) has revised its fiscal 2026 passenger growth target to 206 million, down from the original 210 million, due to delays in Boeing (NYSE:BA) aircraft deliveries. The reduction reflects a modest 3% adjustment as Boeing struggles to meet production timelines for its 737-8200 “Gamechanger” planes.
While Boeing’s production recovers from 2024 disruptions, including a strike, Ryanair anticipates insufficient deliveries to meet initial goals. The airline hopes to recover growth during the summer of 2026 as it expects the remaining 29 Gamechanger aircraft in its 210-unit order to arrive by March 2026. Ryanair is also integrating Boeing's MAX-10 model, with deliveries starting in spring 2027 to support long-term expansion.
Analysts at RBC Capital Markets highlight Ryanair’s low-cost, high-margin business model and project free cash flow (FCF) yields exceeding 10% by FY26, enabling potential shareholder returns. The company is reallocating capacity to markets like Poland, Sweden, and Italy, where aviation policies support growth. Nearly all of its summer 2025 capacity, featuring 164 new routes, is now on sale.
For the December 2024 quarter, Ryanair reported €149 million in after-tax profit, a significant increase from €15 million the prior year. Passenger traffic grew 9% to 45 million, driving a 10% rise in total revenue to €2.96 billion. Ancillary revenue also climbed 10%, fueled by demand for add-ons such as seat selection and priority boarding.
Despite challenges, Ryanair remains committed to its long-term goal of reaching 300 million annual passengers by 2034. For FY25, it projects post-tax profits between €1.55 billion and €1.61 billion, though risks from geopolitical tensions, further Boeing delays, and air traffic control issues could impact outcomes.


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Washington Post Publisher Will Lewis Steps Down After Layoffs
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



